These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1721456)

  • 1. A multicenter clinical open trial of FK 506 in refractory uveitis, including Behçet's disease. Japanese FK 506 Study Group on Refractory Uveitis.
    Mochizuki M; Masuda K; Sakane T; Inaba G; Ito K; Kogure M; Sugino N; Usui M; Mizushima Y; Ohno S
    Transplant Proc; 1991 Dec; 23(6):3343-6. PubMed ID: 1721456
    [No Abstract]   [Full Text] [Related]  

  • 2. [A phase II study of FK506 (tacrolimus) on refractory uveitis associated with Behçet's disease and allied conditions].
    Sakane T; Mochizuki M; Inaba G; Masuda K
    Ryumachi; 1995 Oct; 35(5):802-13. PubMed ID: 8594659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of infliximab on refractory uveitis in Behcet's disease.
    Sayarlioglu M; Cinal A; Topcu N; Demirok A
    Ann Pharmacother; 2004 May; 38(5):901-2. PubMed ID: 15010522
    [No Abstract]   [Full Text] [Related]  

  • 4. Uveitis in juvenile Behçet's disease: clinical course and visual outcome compared with adult patients.
    Kramer M; Amer R; Mukamel M; Snir M; Jaouni T; Friling R
    Eye (Lond); 2009 Nov; 23(11):2034-41. PubMed ID: 19151650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value and complications of immunosuppressive therapy in uveitis of Behcet's disease or of other etiology. Apropos of 40 cases].
    Niessen F; Campinchi R; Bloch-Michel E
    J Fr Ophtalmol; 1982; 5(6-7):407-16. PubMed ID: 7130629
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bolus of cyclophosphamide and methylprednisolone in uveitis in Behçet's disease. Preliminary results with the use of new criteria of evaluation].
    Hamza M; Meddeb S; Mili I; Ouertani A
    Ann Med Interne (Paris); 1992; 143(7):438-41. PubMed ID: 1300863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timing of recurrent uveitis in patients with Behcet's disease receiving infliximab treatment.
    Yamada Y; Sugita S; Tanaka H; Kamoi K; Takase H; Mochizuki M
    Br J Ophthalmol; 2011 Feb; 95(2):205-8. PubMed ID: 20542984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjunctival ulcers in Behçet's disease.
    Zamir E; Bodaghi B; Tugal-Tutkun I; See RF; Charlotte F; Wang RC; Wechsler B; LeHoang P; Anteby I; Rao NA
    Ophthalmology; 2003 Jun; 110(6):1137-41. PubMed ID: 12799237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation criteria for uveitis in Behçet's syndrome].
    Hamza M; Ouertani A
    Rev Rhum Ed Fr; 1993 Apr; 60(4):315-6. PubMed ID: 8167635
    [No Abstract]   [Full Text] [Related]  

  • 10. [Behçet's disease].
    Stokvis JC
    Ned Tijdschr Geneeskd; 1987 Sep; 131(36):1585-6. PubMed ID: 3670445
    [No Abstract]   [Full Text] [Related]  

  • 11. FK506 treatment of noninfectious uveitis.
    Ishioka M; Ohno S; Nakamura S; Isobe K; Watanabe N; Ishigatsubo Y; Tanaka S
    Am J Ophthalmol; 1994 Dec; 118(6):723-9. PubMed ID: 7526689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tacrolimus (FK506) in the treatment of posterior uveitis refractory to cyclosporine.
    Sloper CM; Powell RJ; Dua HS
    Ophthalmology; 1999 Apr; 106(4):723-8. PubMed ID: 10201592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis.
    Ohno S; Nakamura S; Hori S; Shimakawa M; Kawashima H; Mochizuki M; Sugita S; Ueno S; Yoshizaki K; Inaba G
    J Rheumatol; 2004 Jul; 31(7):1362-8. PubMed ID: 15229958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial.
    Tugal-Tutkun I; Mudun A; Urgancioglu M; Kamali S; Kasapoglu E; Inanc M; Gül A
    Arthritis Rheum; 2005 Aug; 52(8):2478-84. PubMed ID: 16052571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blind insight: eyeing anti-tumor necrosis factor treatment in uveitis associated with Behçet's disease.
    Rosenbaum JT
    J Rheumatol; 2004 Jul; 31(7):1241-3. PubMed ID: 15229938
    [No Abstract]   [Full Text] [Related]  

  • 16. Does lowering hyperhomocysteinemia by folic acid beneficial for oculo-Behcet's disease? A pilot study.
    Houman MH; Naffati H; Khanfir M; Ghannouchi M; Ben Ghorbel I; Lamloum M; El Matri L; Hamzaoui K; Jeddi A; Miled M; Fki M
    Tunis Med; 2007 Jun; 85(6):450-3. PubMed ID: 17644895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects.
    Tognon S; Graziani G; Marcolongo R
    Ann N Y Acad Sci; 2007 Sep; 1110():474-84. PubMed ID: 17911463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study.
    Niccoli L; Nannini C; Benucci M; Chindamo D; Cassarà E; Salvarani C; Cimino L; Gini G; Lenzetti I; Cantini F
    Rheumatology (Oxford); 2007 Jul; 46(7):1161-4. PubMed ID: 17478466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical and clinical study of FK506 in uveitis.
    Mochizuki M; Ikeda E; Shirao M; Fujito S; Yoshimura K; Shimada N
    Curr Eye Res; 1992; 11 Suppl():87-95. PubMed ID: 1385045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cyclosporin A in the treatment of uveitis in Behçet's disease: apropos of a case].
    Annonier P; Brini A
    Bull Soc Ophtalmol Fr; 1986 Mar; 86(3):305-8. PubMed ID: 3802341
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.